Literature DB >> 32114721

The rate of acquisition of carbapenemase-producing Enterobacteriaceae among close contact patients depending on carbapenemase enzymes.

Jung Wan Park1,2, Sun Hee Kwak3, Jiwon Jung1,3, Jeong Young Lee3, Young Ju Lim3, Hye Suk Choi3, Min Jee Hong3, Sang Ho Choi1,3, Mi Na Kim1,4, Sung Han Kim1,5.   

Abstract

BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are highly drug-resistant pathogens. Screening the contacts of newly-identified CPE patients is crucial for nosocomial transmission control. We evaluated the acquisition rate of CPE in close contacts as a function of CPE genotype.
MATERIALS AND METHODS: This study was conducted in Asan Medical Center, a 2,700-bed, tertiary teaching hospital in Seoul, Korea, between November 2010 and October 2017. Index cases were defined as patients with positive tests for CPE from any infected or colonized site during hospitalization who had no direct epidemiologic linkage with existing CPE patients; close contact patients were defined as those whose hospital stay overlapped with the stay of an index case for at least one day and who occupied the same room or intensive care unit (ICU). Secondary patients were defined as those who produced positive CPE culture isolates from surveillance cultures that had the same CPE enzyme as that of the index case patients.
RESULTS: A total of 211 index case patients and 2,689 corresponding contact patients were identified. Of the contact patients, 1,369 (50.9%) including 649 New-Delhi metallo-beta-lactamase-1 (NDM-1) and 448 Klebsiella pneumoniae carbapenemase (KPC)-producing CPE exposures were screened, and 44 secondary patients (3.2%; 95% confidence interval 2.3 - 4.3%) were positive for NDM-1-producing CPE (16 patients) and KPC-producing (24 patients) CPE. The CPE acquisition rate (5.4%) for KPC-producing CPE exposures was significantly higher than that for NDM-1 exposures (2.7%) (P = 0.01).
CONCLUSION: The CPE acquisition rate was 3.2% among close contacts sharing a multi-patient room, with about a two-fold higher risk of KPC-producing CPE than NDM-1-producing CPE.
Copyright © 2020 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy.

Entities:  

Keywords:  Acquisition rate; Carpapenemase-producing Enterobacteriaceae; Klebsiella pneumoniae carbaepenamse; New Delhi Metallo-beta-lactamase-1

Year:  2020        PMID: 32114721

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


  4 in total

1.  Prolonged Carriage of Carbapenemase-Producing Enterobacteriaceae: Clinical Risk Factors and the Influence of Carbapenemase and Organism Types.

Authors:  Yong Kyun Kim; In Bok Chang; Han Sung Kim; Wonkeun Song; Seung Soon Lee
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

2.  Targeted Molecular Detection of Nosocomial Carbapenemase-Producing Gram-Negative Bacteria-On Near- and Distant-Patient Surfaces.

Authors:  Claudia Stein; Isabel Lange; Jürgen Rödel; Mathias W Pletz; Frank Kipp
Journal:  Microorganisms       Date:  2021-05-31

3.  Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea.

Authors:  Jin Ju Park; Yu Bin Seo; Jacob Lee; Joong Sik Eom; Wonkeun Song; Young Kyun Choi; Sung Ran Kim; Hee Jung Son; Nan Hyoung Cho
Journal:  J Korean Med Sci       Date:  2020-09-14       Impact factor: 2.153

Review 4.  Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria.

Authors:  Hyo-Jin Lee; Dong-Gun Lee
Journal:  Korean J Intern Med       Date:  2022-02-28       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.